Advanced SearchSearch Tips
A Comparative Study on the Herbal Prescription and the Herbal Substance of Atractylodis Rhizoma Alba by HPLC analysis
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : Herbal Formula Science
  • Volume 24, Issue 2,  2016, pp.71-79
  • Publisher : The Korean Journal of Oriental Medical Prescription
  • DOI : 10.14374/HFS.2016.24.2.71
 Title & Authors
A Comparative Study on the Herbal Prescription and the Herbal Substance of Atractylodis Rhizoma Alba by HPLC analysis
Cho, Hyun Joo; Jeon, Yoon Jae; Kim, Nam-Gil; Choi, Hyug-Yong;
  PDF(new window)
Objectives : To verify the equivalence between Atractylodis Rhizoma Alba herbal prescription(HP-ARA) and Atractylodis Rhizoma Alba herbal sub stance(HS-ARA). Methods : Safety tests by microbial regulation and heavy metal analysis (total heavy metal, Pb, As) and a stability test by long term shelf test for HP-ARA according to notification of the Ministry of Food and Drug Safety were carried out. Then, multi component profile of HP-ARA and HS -ARA were analyzed by HPLC. Results : The safety and stability of HP-ARA confirmed by several tests. Correlation coefficient of equivalence of HP-ARA and ARA-HS showed 0.992. Conclusion : Based on this result of equivalence between HP-ARA and HS-ARA, HP-ARA can substitute HS-ARA used to make herbal medicines (herbal decoction, pills and powder).
Herbal medicines;Atractylodis Rhizoma Alba;Safety;Stability;Correlation coefficient;
 Cited by
Ministry of Health and Welfare and Food and Drug Administration of Republic of Korea. Article 2, paragraph 5 of the PHARMACEUTICAL AFFAIRS ACT. 2015 Oct [cited 2015 Dec]; Available from:URL:법령/약사법/(13320,20150518)

Ministry of Health and Welfare. Article 2, paragraph 4 0f the ACT ON THE PROMOTION OF KOREAN MEDICINE AND PHARMACEUTICALS. 2012 Oct [cited 2015 Dec]; Available from:URL:법령/한의약육성법/(11524,20121022).

Shin HK. Study on the direction of policies to manage and develop herbs and their products. J Korean Oriental Med. 2000; 20(2):14-24.

The publication commission of Year Book of Korea Medicine. Year Book of Traditional Korean Medicine. 2012. Institute of Oriental Medicine, Association of Korean Medicine, Pusan National University School of Korean Medicine. 2013: 232-233.

Guideline on declaration of herbal substances and herbal preparations 1 in herbal medicinal products 2 /traditional herbal medicinal products. 2010. European Medicines Agency.

National Institute of Food and Drug Safety Evaluation. 2009. Establishment and Revision of the Official Pharmacopoeia on Herbal Medicines, 1-5.

Rural development administration. 2006. Studies on the good agriculture practices and standard of first processing in herbal medicines, 15-17.

National Institute of Food and Drug Safety Evaluation., 2013. Development Study of on-line educational contents for Herbal Medicine Research Institutes, 16-18.

Korea Institute of Oriental Medicine., 2011. Guidance for Herbal Good Manufacturing Practice, 5-7.

Seong kyu Park., Chung sook Kim., Xun Cui., Yun kyung Kim., 2004. Reviews: For Improvement of Administration System of Herbal Medicine as Authorized Drugs. Korea Journal of Herbalogy 19, 187-193.

The Society of Korean Official Compendium for Public Health., 2009. The Korean Pharmacopoeia

Ji-Hoon Kim, Sun-Young Cho, Sang-Yong Han, Sun-Dong Park, Yun-Kyung Kim., 2015. Suggestion about Modernized Classification of Herbal Medicinal Preparations in Dual Medical Systems. J Korean Med. 36(1):61-74 crossref(new window)

Korea Food & Drug Administration., 2011. Food & Drug Statistical Yearbook, 285-286.

Min Kyung Choi., Hyeong Geug Kim., King Hua Wang., Chang Gue Son., 2011. The Application of High Performance Thin Layer Chromatography for Herbal Formula Standardization. Journal of Korean Oriental Medicine 32, 68-74.

Woong Mo Yang., 2010. Fundamental study for hGMP operational system implementation. National Institute of Food and Drug Safety Evaluation,30-38.

Woo Hyun Paik., 2004. Studies on the Improvement of GMP Regulation for Herbal Preparations. Korea Pharmaceutical Manufacturers Association, 25-35.